Menopause & Your Heart

"For most of our reproductive years, estrogen quietly acts as a guardian of the heart. When it falls away at menopause, that protection doesn't just diminish — it disappears almost overnight."

Heart disease kills more women than all cancers combined. Yet most women — and many doctors — still think of it as a man's condition. The result is that women are under-screened, under-diagnosed, and often under-treated for one of the most significant health risks of midlife and beyond.

The menopause transition is a critical window. The hormonal shifts happening in your 40s and 50s don't just cause hot flushes and sleep problems — they are actively reshaping your cardiovascular system. Understanding what's happening, why it matters, and what you can do about it may be one of the most important things you read this year.

A note before we begin This article covers the well-established link between menopause and cardiovascular health. It is not intended to frighten you — most of these risks are modifiable, and awareness is your most powerful tool. If you have existing heart conditions, please discuss your individual risk profile with your GP or cardiologist.

What Does Estrogen Actually Do for the Heart?

Estrogen isn't just a reproductive hormone. Receptors for estrogen exist throughout the cardiovascular system — in the heart muscle itself, in the walls of blood vessels, and in the cells that line your arteries. When estrogen levels are healthy, it performs a remarkable range of protective functions.

It helps keep artery walls flexible and responsive, supports healthy blood flow, reduces inflammation in blood vessels, keeps LDL ("bad") cholesterol lower and HDL ("good") cholesterol higher, and helps regulate blood pressure. It also plays a role in keeping blood sugar stable and reducing the tendency for blood to clot inappropriately.

In short, estrogen is doing a significant amount of cardiovascular housekeeping every single day — work that goes largely unnoticed until it stops.

The Protective Window

Before menopause, women have significantly lower rates of heart disease than men of the same age. After menopause — particularly in the decade that follows — that gap closes rapidly. By age 65–70, women's cardiovascular risk equals, and in some studies exceeds, that of men. This shift is not coincidental. It tracks almost precisely with the loss of oestrogen.

What Changes at Menopause — and Why It Matters

The hormonal changes of perimenopause and menopause set off a cascade of cardiovascular shifts. These don't happen all at once — they unfold gradually over years — but the direction of travel is consistent and significant.

Cholesterol Profile Shifts

One of the most consistent findings in research is that the menopause transition causes a worsening of the cholesterol profile. LDL cholesterol rises, HDL cholesterol falls, and triglycerides increase. These changes begin in perimenopause — often before periods have stopped — and accelerate in the years immediately following the final period. For many women, this is the first time in their lives that their cholesterol results look concerning on a blood test.

Blood Pressure Rises

Hypertension becomes dramatically more common in women after menopause. Before the age of 55, women are actually less likely than men to have high blood pressure. After menopause, this reverses — and by age 65, women are more likely than men to be hypertensive. The loss of oestrogen's vasodilatory effects, combined with changes in the renin-angiotensin system (which regulates blood pressure), drives this increase.

Insulin Resistance and Blood Sugar

Estrogen helps maintain insulin sensitivity. As it falls, cells become less responsive to insulin, blood sugar regulation becomes less efficient, and the risk of developing type 2 diabetes increases. Central weight gain — the accumulation of fat around the abdomen that becomes common in menopause — compounds this effect. Abdominal fat is metabolically active and directly associated with increased cardiovascular risk.

Arterial Stiffness

Healthy arteries are elastic — they expand and contract with each heartbeat, buffering pressure. Oestrogen helps maintain this elasticity. After menopause, arteries stiffen more quickly than they otherwise would, increasing the workload on the heart and raising systolic blood pressure. Arterial stiffness is an independent predictor of heart attack and stroke.

Inflammation

Estrogen has significant anti-inflammatory effects on the cardiovascular system. Its decline is associated with increased levels of inflammatory markers — including C-reactive protein (CRP) — that are linked to the development of atherosclerosis (the buildup of plaques in artery walls).

Does HRT Protect Your Heart?

This is one of the most nuanced — and most debated — questions in women's health. The short answer is: it depends on when you start, what type you use, and your individual health profile. Here's where the science currently stands.

The "Timing Hypothesis" — Why Starting Early May Matter

Research — including the Women's Health Initiative and the DOPS trial — suggests that when HRT is started early in the menopause transition (within 10 years of the final period, or before age 60), it may actually reduce the risk of cardiovascular disease. When started much later — in women who already have established cardiovascular disease or atherosclerosis — it appears to offer less benefit and may carry some risk.

This is sometimes called the "window of opportunity" or the timing hypothesis. It remains an area of active research, but current guidance from leading menopause societies supports early initiation of HRT in appropriate candidates, and does not classify HRT as harmful to the heart in healthy women under 60.

Transdermal vs. Oral Oestrogen

The route of administration matters significantly. Oral oestrogen is processed by the liver, which can raise triglycerides and certain clotting factors. Transdermal oestrogen — patches, gels, and sprays — bypasses the liver and is considered the safer option for women with cardiovascular risk factors, hypertension, or personal or family history of blood clots. If heart health is a concern, discuss the transdermal route with your prescriber.

Body-Identical Progesterone

The type of progestogen used in combined HRT also appears to matter. Synthetic progestogens (progestins) used in some older forms of HRT may partially counteract oestrogen's beneficial effects on blood vessels. Micronised progesterone (such as Utrogestan) — which is body-identical to the progesterone the body naturally produces — has a more neutral or even favourable cardiovascular profile and is generally preferred for women with heart health concerns.